GLP-1 Drugs in Question | Montpelier News

UVM Health Network is pulling coverage for GLP-1 weight-loss drugs, impacting hundreds of employees and saving nearly $19 million — but for users like Mike Popovitch, who lost 35 pounds in three weeks, it’s devastating news. As employers nationwide reassess ballooning prescription costs, the move reflects a growing trend to curb spending — even as research remains unclear on long-term savings. While diabetes and other medical uses stay covered, those relying on these drugs for weight loss now face steep out-of-pocket costs, forcing a painful choice between health and finances. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/3e735e0ebefcbdde